Andrew Brookes/Getty Images
- Prescription drugs designed by AI could be in clinical trials within years, DeepMind's CEO predicted.
- Demis Hassabis said in an interview he'd be "disappointed" if it took more than a couple of years.
- Clinical trials help evaluate if a drug is safe and effective; drugs may still never hit the market even if they undergo clinical testing.
One of the foremost figures in AI thinks prescription drugs designed by AI could reach clinical testing in a few years.